Surgical options and outcomes in Barrett's esophagus

Current Opinion in Gastroenterology

Volumn 23, Issue 4, 2007, Pages 452-455

  Zaninotto, Giovanni ^a,c   Rizzetto, Christian ^b  

^a SS Giovanni e Paolo Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Barrett's esophagus; Gastroesophageal reflux; Intestinal metaplasia; Nissen fundoplication

Indexed keywords

BARRETT ESOPHAGUS; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE METAPLASIA; LAPAROSCOPIC SURGERY; REVIEW; ROUX Y ANASTOMOSIS; STOMACH FUNDOPLICATION; VAGOTOMY;

BARRETT ESOPHAGUS; ESOPHAGUS; FUNDOPLICATION; HUMANS; LAPAROSCOPY; METAPLASIA;

EID: 34249942186     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3281299152     Document Type: Review

References (22)

1. Goldblum JR, Rice TW. The columnar-lined esophagus. In: Pearson FG, editor. Esophageal surgery. New York: Churchill Livingstone; 1995. pp. 273-282.
2. Sampliner RE. Barrett's esophagus, a complication of GERD. Curr Treat Options Gastroenterol 2002; 5:45-50.
3. Oh DS, Hagen JA, Fein M, et al. The impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg 2006; 10:787-796. This paper suggests that gastric juice composition is the primary determinant of inflammatory mucosal injury and subsequent loss of esophageal function, emphasizing the key role of bile salts in the genesis of Barrett's esophagus.
4. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985; 313:857-859.
5. Burkert J, Wright NA, Alison MR. Stem cells and cancer: an intimate relationship. J Pathol 2006; 209:287-297. An interesting view on the tumour carcinogenesis of gastrointestinal tract. The potential role of self-renewing stem cells which seem to be entirely responsible for sustaining the tumour as well as giving rise to proliferating but progressively differentiating cells that are responsible for much of the cellular heterogeneity.
6. DeMeester TR. Surgical therapy for Barrett's esophagus: prevention, protection and excision. Dis Esophagus 2002; 15:109-116.
7. Brandt MG, Darling GE, Miller L. Symptoms, acid exposure and motility in patients with Barrett's esophagus. Can J Surg 2004; 47:47-51.
8. Dallemagne B, Weerts JM, Jehaes C, et al. Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc 1991; 1:138-143.
9. Farrell TM, Smith CD, Metreveli RE, et al. Fundoplication provides effective and durable symptom relief in patients with Barrett's esophagus. Am J Surg 1999; 178:18-21.
10. Abbas AE, Deschamps C, Cassivi SD, et al. Barrett's esophagus: the role of laparoscopic fundoplication. Ann Thorac Surg 2004; 77:393-396.
11. Zaninotto G, Cassaro M, Pennelli G, et al. Barrett's epithelium after antireflux surgery. J Gastrointest Surg 2005; 9:1253-1260.
12. Cowgill SM, Al-Saadi S, Villadolid D, et al. Does Barrett's esophagus impact outcome after laparoscopic Nissen fundoplication? Am J Surg 2006; 192:622-626. A well designed study aiming to show how laparoscopic Nissen fundoplication can obtain similar symptom relief in patients with and without Barrett's esophagus.
13. Ozmen V, Oran ES, Gorgun E, et al. Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus. Surg Endosc 2006; 20:226-229. This paper reports good results of laparoscopic Nissen fundoplication in patients with Barrett's esophagus.
14. Chen LQ, Ferraro P, Martin J, Duranceau AC. Antireflux surgery for Barrett's esophagus: comparative results of the Nissen and Collis-Nissen operations. Dis Esophagus 2005; 18:320-328.
15. Brand DL, Ylviaakev JT, Gelfand M, Pope CE. Regression of columnar esophagus (Barrett's) epithelium after antireflux surgery. New Engl J Med 1980; 302:844-848.
16. Gurski RR, Peters JH, Hagen JA, et al. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 2003; 196:706-712.
17. Oelschlager BK, Barreca M, Chang L, et al. Clinical and pathologic response of Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 2003; 238:458-464.
18. Biertho L, Dallemagne B, Dewandre JM, et al. Laparoscopic treatment of Barrett's esophagus: long-term results. Surg Endosc 2007; 21:11-15. This study suggests that laparoscopic fundoplication offers a safe and effective long-term treatment for Barrett's esophagus.
19. Csendes A, Braghetto I, Burdiles P, et al. Regression of intestinal metaplasia to cardiac or fundic mucosa in patients with Barrett's esophagus submitted to vagotomy, partial gastrectomy and duodenal diversion. A prospective study of 78 patients with more than 5 years of follow up. Surgery 2006; 139:46-53. The paper suggests that this complex operation (vagotomy and antrectomy combined with duodenal bile diversion) may become an attractive option as a definitive surgical treatment in patients with long segment Barrett's esophagus.
20. Rossi M, Barreca M, de Bortoli N, et al. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg 2006; 243:58-63. A well designed study that suggests how the surgical treatment may be more effective than medical therapy to modify the natural history of LGD in patients with Barrett's esophagus by controlling not only acid but also biliopancreatic reflux into the esophagus.
21. Zaninotto G, Rugge M. Regression of low-grade noninvasive neoplasia in Barrett's epithelium: should we lower our guard? Ann Surg 2007; 245:337-338. An interesting comment that stressed one more time the importance of the endoscopic surveillance of Barrett's esophagus.
22. Shaheen NJ. Does fundoplication change the risk of esophageal cancer in the setting of GERD? Am J Gastroenterol 2005; 100:1009-1011.